A. Vitamin K
B. Barbiturates
C. Acetominophen
D. Acetyl salicylic acid
A. Vitamin K
B. Barbiturates
C. Acetominophen
D. Acetyl salicylic acid
A. It inhibits thromboxanes
B. It stimulates Prostacyclins
C. It is a vasodilator
D. Ithelps in reducing inflammatory aggregate
A. Naloxone
B. Nalosphine
C. Nalpuphine
D. Methadine
A. Remifentanil
B. Morphine
C. Sufentanil
D. Fentanyl
A. Analgesia is associated with μ and k receptors
B. Dysphoria is associated with S receptors
C. NSAIDS benefit by preventing prostaglandin synthesis
D. Naloxane is a non-competitive antagonist and irreversibly opposes the opioids
A. Reye’s syndrome
B. Nausea
C. Diarrhoea
D. Acid-base imbalance
A. Respiratory alkalosis
B. Haemorrhage
C. Hepatic necrosis
D. Gastric Ulceration
A. Aspirin
B. Ibuprufen
C. Diclofenac potassium
D. Mefenamic acid
E. Both A & B
A. Diphenhydramine
B. Atroe
C. Naloxane
D. Nalorphine
A. Limbic system
B. Emetic system
C. Chemoreceptor trigger zone (CTZ)
D. Opioid receptors in G.I.T